HCMT
GTHX

Highland Capital Management (Texas)’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Highland Capital Management (Texas)’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,000
Closed -$192K – 350
2018
Q4 		$192K Sell
10,000
-5,000
-33% -$187K 0.01% 253
2018
Q3 		$784K Buy
+15,000
New +$818K 0.04% 188

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Highland Capital Management (Texas)'s GTHX Position: Q1 2019 in Review

Highland Capital Management (Texas) sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2019, closing a stake of 10,000 shares — an estimated $192K sold.

Highland Capital Management (Texas) first reported a position in GTHX in Q3 2018 and held it in 2 quarters. The position peaked at $784K in Q3 2018. 93 funds tracked by Wall St. Rank hold GTHX as of Q1 2019.

  • Highland Capital Management (Texas) reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 10,000 G1 Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $192K.
  • Highland Capital Management (Texas) first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2018 and held it in 2 quarters.
  • Highland Capital Management (Texas)'s G1 Therapeutics, Inc. Common Stock position peaked at $784K in Q3 2018.
  • 93 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2019, filed 15 May 2019.